# Sequentify

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sequentify

- Industry: Medical Devices & Equipment
- Headquarters: Rehovot, Israel
- Website: www.sequentify.com
- Total disclosed funding: $7M
- Latest round: Seed (May 10, 2022)
- Investors on record: 1

## About

Founded in 2021 and based in Rehovot, Israel, Sequentify Ltd. is a biotechnology company offering novel library-prep solutions for genome sequencing. The company also allows researchers to do genomic diagnostics. The company is co-founded by Ophir Herbst, Tamir Biezuner, Ph.D., Tom Fleischer, Ph.D. All of the founder's team serve as the company's board member. The company was founded via a spinoff of a Weizmann Institute of Science. It exit stealth mode via a fund round in May 2022 -- it raised USD 7 million in a seed round led by OurCrowd.

The company's solution covers five sequencing phases -- template extraction, library prep, sequencing, secondary analysis, and tertiary analysis. Compared with traditional sequencing services, the company's solution is automated, simplified, and can be adapted to a population-wide scale.

## Funding rounds

- Seed, May 10, 2022, $7M — OurCrowd

## Investors

- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Seed